The Immunomodulatory Small Molecule Imiquimod Induces Apoptosis in Devil Facial Tumour Cell Lines
Author:
Funder
Australian Research Council
University of Tasmania Foundation through funds raised by the Save the Tasmanian Devil Appeal
Publisher
Public Library of Science (PLoS)
Subject
Multidisciplinary
Reference52 articles.
1. Modulation of TH1 and TH2 cytokine production with the immune response modifiers, R-848 and imiquimod;TL Wagner;Cell Immunol,1999
2. Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway;H Hemmi;Nat Immunol,2002
3. Plasmacytoid dendritic cells produce cytokines and mature in response to the TLR7 agonists, imiquimod and resiquimod;SJ Gibson;Cell Immunol,2002
4. Interferon-alpha and interleukin-12 are induced differentially by Toll-like receptor 7 ligands in human blood dendritic cell subsets;T Ito;J Exp Med,2002
5. Disease-independent skin recruitment and activation of plasmacytoid predendritic cells following imiquimod treatment;M Urosevic;J Natl Cancer Inst,2005
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Beyond inhibition against the PD-1/PD-L1 pathway: development of PD-L1 inhibitors targeting internalization and degradation of PD-L1;RSC Medicinal Chemistry;2024
2. Early redox homeostasis disruption contributes to the differential cytotoxicity of imiquimod on transformed and normal endothelial cells;Experimental Dermatology;2021-11-16
3. LXR stimulates a metabolic switch and reveals cholesterol homeostasis as a statin target in Tasmanian devil facial tumor disease;Cell Reports;2021-03
4. Recent Advances in the Development of PD-L1 Modulators: Degraders, Downregulators, and Covalent Inhibitors;Journal of Medicinal Chemistry;2020-12-04
5. Curse of the devil: molecular insights into the emergence of transmissible cancers in the Tasmanian devil (Sarcophilus harrisii);Cellular and Molecular Life Sciences;2020-01-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3